Tirzepatide
Also known as: GIP/GLP-1 dual agonist · Mounjaro / Zepbound (brand names)
A long-acting dual GIP and GLP-1 receptor agonist that mimics two gut hormones to regulate appetite and blood sugar, best known as the active ingredient in widely prescribed metabolic medications.
Class
GIP/GLP-1 dual agonist
Default unit
mg
Common route
Subcutaneous
Typical half-life
~5 days
Frequency
Once weekly
Commonly associated areas
Illustrative map of the body systems Tirzepatide is most often discussed in relation to. Relative emphasis only — not a measure of efficacy or a medical claim.
Proposed mechanisms / pathways
What is Tirzepatide?
Tirzepatide is a dual GIP and GLP-1 receptor agonist — a long-acting peptide that activates two different gut-hormone receptors at once. It is the active ingredient in widely prescribed, FDA-approved medications for type 2 diabetes and weight management. Its once-weekly dosing comes from a half-life of roughly five days, and it is one of the few agents in a tracking app that exists primarily as a regulated pharmaceutical rather than a research compound.
How it is thought to work
Tirzepatide is reported to act on both the GIP and GLP-1 receptors, two pathways that the body normally uses to manage blood sugar and appetite after eating. By engaging both, it is thought to support insulin release when glucose is high, slow gastric emptying so fullness lasts longer, and act on appetite centers to reduce hunger and food cravings. The combined effect tends to show up as gradual, steady changes in weight and appetite rather than anything immediate.
Educational only — not medical advice
Tirzepatide is a prescription medication that should only be used under the supervision of a licensed healthcare provider. Nothing here is a recommendation, dose, or medical claim — it is general education to help you track a protocol your provider has set.
Tracking Tirzepatide in LynkDose
Tirzepatide is titrated — the dose steps up over weeks to let your body adjust and limit side effects. That makes record-keeping especially valuable: in LynkDose you can log each weekly dose with its date, mark when the dose increases, do a consistent weekly weigh-in, and note appetite and any side effects. With that history, a plateau or a rough week becomes something you can see and discuss with your provider, not guess at.
Commonly discussed for
- Appetite and craving regulation
- Blood-sugar management
- Weight-management protocols under medical supervision
Often stacked: Generally used on its own rather than stacked; combination approaches with agents such as cagrilintide are explored in research settings.
How to track Tirzepatide in LynkDose
Tirzepatide is titrated upward over weeks, so logging the date of every dose change is the most useful thing to record — it lets you tie weight, appetite, and side effects to a specific dose step.
Deeper read: Tracking GLP-1 Peptides (Semaglutide & Tirzepatide)
Not medical advice
This page is educational and does not recommend, prescribe, or dose any compound. Many peptides are research chemicals not approved for general human use. Always consult a qualified healthcare provider and follow the laws in your area.